Skip to main content
. 2013 Sep 15;27(18):1959–1973. doi: 10.1101/gad.223339.113

Figure 6.

Figure 6.

Correlating c-FOS levels and MMP10 and S100A15 in SCCs but not in BCCs or perilesional healthy skin. (A, top) c-FOS immunostainings on human “perilesional” skin (n = 20), BCCs (n = 85), and SCCs (n = 46). (Middle) MMP10 immunostainings on human “perilesional” skin (n = 20), BCCs (n = 85), and SCCs (n = 42). (Bottom) CD4 immunostainings on human “perilesional” skin (n = 20), BCCs (n = 85), and SCCs (n = 42). (Below) Correlation of c-FOS and MMP10 expression levels on human SCC immunostainings. (B) S100A15 immunostainings on human healthy skin (n = 20), BCCs (n = 85), and SCCs (n = 66).

HHS Vulnerability Disclosure